7:30 AM | Reoperation of Aortic Valve Replacement Using Sutureless Aortic Valve for Early Degeneration and Thrombosis after Transcatheter Aortic Valve Implantation (TAVI) Case Presenter: Hyo-Hyun Kim |
7:40 AM | Transcatheter Aortic Valve Implantation For The Patient With Very Small Annulus Case Presenter: Yusuke Kobari |
7:50 AM | Invited Case Presentation: LAAC with Zero Fluoro via ICE Guidance Lecturer: Huimin Chu |
8:00 AM | Invited Case Presentation: Acute Femoral Occlusion After Adjunctive Angio-Seal Usage in Vascular Closure Following Transcatheter Aortic Valve Replacement Lecturer: Mao-Shin Lin |
8:10 AM | Invited Case Presentation: Dedicated TAVR Device for Pure Native AR Lecturer: Anthony Yiu Tung Wong |
8:30 AM | Asan Medical Center, Seoul, Korea: Case #7 |
8:30 AM | Asan Medical Center, Seoul, Korea: Case #8 |
8:30 AM | Asan Medical Center, Seoul, Korea: Case #7, #8 Echo Interpreter: Dae-Hee Kim |
9:30 AM | Minimalist TAVR: AMC Experience Lecturer: Seung-Jung Park |
9:38 AM | Current Status of TAVR in Korea and US: TP-TAVR Registry Lecturer: Duk-Woo Park |
9:46 AM | Current Status of TAVR in Japan Lecturer: Kentaro Hayashida |
9:54 AM | Coronary Access After TAVR Lecturer: Edgar Lik-Wui Tay |
10:02 AM | Choosing the Right Device for the Right Anatomy Lecturer: Cheung Chi Simon Lam |
10:12 AM | Minimalistic Approach to LAAO Under Intra-cardiac Echocardiographic Guidance Lecturer: Shing Him Cheung |
10:22 AM | Post LAAO Anti-thrombotic Regimens and for How Long After the Closure Lecturer: Anthony Yiu Tung Wong |
10:32 AM | Discussion and Audience Interaction |
10:40 AM | Asan Medical Center, Seoul, Korea: Case #9 |
10:40 AM | Asan Medical Center, Seoul, Korea: Case #9 Echo Interpreter: Seung-Ah Lee |
10:40 AM | Asan Medical Center, Seoul, Korea: Case #10 |
10:40 AM | Asan Medical Center, Seoul, Korea: Case #10 Echo Interpreter: Geu-Ru Hong |
11:30 AM | Is LAA Closure a Valid Alternative? No, NOACs Are Strongly Preferred to LAA Closure! Lecturer: |
11:40 AM | LAAO Is Becoming a First Line Option. Lecturer: Seung Yong Shin |
11:50 AM | Discussion and Audience Interaction |
12:00 PM | Optimizing Stroke Prevention with NOACs Focused on Updated Studies of Edoxaban Lecturer: Eue-Keun Choi |
12:15 PM | Clinical Challenges in CKD Patients with AF: Renal Safety of Rivaroxaban Lecturer: Hong Euy Lim |
12:30 PM | The Optimal Antithrombotic Strategy in Patients with AF and ACS: Focusing on the AUGUSTUS Trial Lecturer: Kyung Woo Park |
12:45 PM | Discussion and Audience Interaction |
1:00 PM | Asan Medical Center, Seoul, Korea: Case #11 1st Operator: Suk Jung Choo 2nd Operator: Duk-Woo Park 3rd Operator: Ho Jin Kim 4th Operator: Euihong Ko |
1:00 PM | Asan Medical Center, Seoul, Korea: Case #12 |
1:00 PM | Asan Medical Center, Seoul, Korea: Case #11, #12 Echo Interpreter: Dae-Hee Kim |
2:00 PM | Who Should Not Undergo TAVR? Key Insights from the Pivotal Trials and Registries Lecturer: David Joel Cohen |
2:10 PM | Optimal Antithrombotics After TAVR Lecturer: Duk-Woo Park |
2:20 PM | The Next Target of the Valvular Intervention: Future Perspectives Lecturer: Eberhard Grube |
2:30 PM | Discussion and Audience Interaction |
2:50 PM | Take Home Message & Closing Remark Speaker: Duk-Woo Park |
8:50 AM | Imaging Planning for Device Type and Size Selection Lecturer: Jung-Sun Kim |
9:10 AM | LAA Closure: Step-by-Step from Septal Puncture to Device Detachment Lecturer: Cheung Chi Simon Lam |
9:30 AM | LAA Closure Simulator: Hands-on Teaching Trainer: Pil Hyung Lee |
10:10 AM | CT Planning for SAPIEN 3 Lecturer: Euihong Ko |
10:30 AM | SAPIEN 3: Step-by-Step from Puncture to Closure Lecturer: Kentaro Hayashida |
10:50 AM | SAPEIN 3 TAVR Simulator: Hands-on Teaching Trainer: Duk-Woo Park |